Immune Therapy Holdings (Sweden)
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis treatment for immune mediated inflammatory diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Immune Therapy Holdings (Sweden), Sweden, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
81%
Total
Publications
54
Total Open
Publications
44
Total
Citations
698
Open Access
Percentage
81%
Total
Publications
54
Total Open
Publications
44
Total
Citations
698
Breakdown
Publisher Open
33%
Both
37%
Other Platform Open
11%
Closed
19%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 26%
10
Hybrid 40%
15
No Guarantees 34%
13
Other Platform Open
Domain 77%
20
Institution 23%
6
Other Internet 19%
5
Preprint 8%
2
Public 4%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 20 |
Europe PMC | Domain | 6 |
KTH Royal Institute of Technology - KTH Publication Database DiVA | Other Internet | 3 |
University of Szeged - SZTE Publicatio Repozitórium - SZTE - Repository of Publications | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
Goethe University Frankfurt - Publication Server of Goethe University Frankfurt am Main | Institution | 2 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 2 |
Aalborg Universitet - VBN Forskningsportal | Other Internet | 2 |
Uppsala University - Uppsala University Publications | Institution | 1 |
University of Toronto - TSpace | Institution | 1 |